Old Web
English
Sign In
Acemap
>
authorDetail
>
Vishal Ghori
Vishal Ghori
Medicine
Internal medicine
Diabetes mellitus
Biosimilar
Immunogenicity
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta® in Healthy Subjects: a Randomized, Double-blind Trial
2020
Clinical Therapeutics
Jason D. Lickliter
Radmila Kanceva
Emmanuelle Vincent
Armin Schueler
Eleanor Harrison-Moench
Corinne Seng Yue
Michael Stahl
Martin Ullmann
Vishal Ghori
Paul Griffin
Show All
Source
Cite
Save
Citations (1)
Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial
2020
Pharmacology Research & Perspectives
Chris Wynne
Christian Schwabe
Emmanuelle Vincent
Armin Schueler
Janka Ryding
Martin Ullmann
Vishal Ghori
Radmila Kanceva
Michael Stahl
Show All
Source
Cite
Save
Citations (1)
Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis
2019
Clinical Rheumatology
Christopher J. Edwards
Joëlle Monnet
Martin Ullmann
Pantelis Vlachos
V. Chyrok
Vishal Ghori
Show All
Source
Cite
Save
Citations (13)
Evaluate Cardiovascular Risk Factor in Indian Insulin Sensitive &Resistant Subjects Using Lipid Profile & Visceral Fat Measurement
2013
Diabetes
Komal Makwana
Komal Kalasava
Vishal Ghori
Show All
Source
Cite
Save
Citations (0)
1
map